Comparative study between the creams Ozenoxacin and Nadifloxacin in facial Acne

A Comparative study on efficacy and safety of topical ozenoxacin 1 WW cream versus topical nadifloxacin 1 WW cream in mild to moderate facial acne vulgaris A randomized control trial - NIL

Status

Recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/01/061760

Enrollment

Registered

2024-01-23

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nadifloxacin cream: Nadifloxacin 1% W/W Cream topical application twice daily for 2 months Intervention2: Ozenoxacin cream: Ozenoxacin 1% W/W Cream topical application twice daily for 2

Eligibility

Inclusion criteria

Inclusion criteria: Acne grades 1,2,3 At least 10 lesions Agreed to sign consent

Exclusion criteria

Exclusion criteria: Usage of topical treatment I’m last 2 weeks, systemic antibiotics in last 4 weeks, chemical peeling in last 3 months, systemic isotretinoin in last 6 months Hypersensitive to quinolones Photosensitive condition/drugs Pregnant/Lactating women

Design outcomes

Primary

Measure	Time frame
Total lesion countTimepoint: 2 months	—

Secondary

Measure	Time frame
Global assessment by patientTimepoint: 2 months	—

Countries

India

Contacts

Public ContactDr Ashish Deshmukh

MGM MEDICAL COLLEGE

ashish7557@gmail.com9422213292

Outcome results